|
Volumn 4, Issue 2, 2004, Pages 11-18
|
Inhibition of COX isoforms by nutraceuticals
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMENTOFLAVONE;
BERBERINE;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
GLUCOSAMINE;
IBUPROFEN;
INDOMETACIN;
IPRIFLAVONE;
MAGNESIUM DERIVATIVE;
MAGNESIUM SALVINOLIC ACID;
MSV 60;
NAPROXEN;
NEXRUTINE;
PANAX NOTOGINSENG EXTRACT;
PROSTAGLANDIN SYNTHASE;
RESVERATROL;
ROFECOXIB;
RUSCUS EXTRACT;
SALVIA MILTIORRHIZA EXTRACT;
UNCLASSIFIED DRUG;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CELL PROTECTION;
CONCENTRATION RESPONSE;
ENZYME INHIBITION;
HUMAN;
KIDNEY INJURY;
MINIMUM INHIBITORY CONCENTRATION;
MULTIPLE REGRESSION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
STOMACH ULCER;
BIFLAVONOIDS;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
INFLAMMATION;
ISOENZYMES;
ISOFLAVONES;
MEMBRANE PROTEINS;
NEOPLASMS;
PLANT EXTRACTS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RUSCUS;
STILBENES;
|
EID: 8744230804
PISSN: 15228940
EISSN: None
Source Type: Journal
DOI: 10.1300/J157v04n02_02 Document Type: Article |
Times cited : (35)
|
References (7)
|